ROCKVILLE, Md., March 3 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that a panel presentation and discussion at the Susquehanna Financial Group Second Annual SIGnificant Investment Options in Healthcare Conference will be webcast and may be accessed at http://www.hgsi.com.
A senior member of Human Genome Sciences' clinical management team will participate in a panel presentation and discussion entitled "Potential New Therapies in SLE" on Wednesday, March 5, 2008.
Investors interested in listening to a replay of this panel discussion should log on after 6:00 pm on March 5, 2008 to access the audio recording.
The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.
HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company's web site at http://www.hgsi.com.
|SOURCE Human Genome Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved